SenesTech, Inc. (SNES) Surges to 52-Week Low, Is Now Worst Performer

May 16, 2018 - By Margaret Downey

The stock of SenesTech, Inc. (NASDAQ:SNES) hit a new 52-week low and has $0.31 target or 4.00 % below today’s $0.32 share price. The 9 months bearish chart indicates high risk for the $5.29 million company. The 1-year low was reported on May, 16 by Barchart.com. If the $0.31 price target is reached, the company will be worth $211,600 less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 5.91% or $0.02 during the last trading session, reaching $0.32. About 225,872 shares traded or 143.45% up from the average. SenesTech, Inc. (NASDAQ:SNES) has declined 93.41% since May 16, 2017 and is downtrending. It has underperformed by 104.96% the S&P500.

More notable recent SenesTech, Inc. (NASDAQ:SNES) news were published by: Benzinga.com which released: “45 Biggest Movers From Yesterday” on May 16, 2018, also Benzinga.com with their article: “37 Stocks Moving In Tuesday’s Mid-Day Session” published on May 15, 2018, Streetinsider.com published: “SenesTech, Inc. (SNES) Misses Q1 EPS by 1c” on May 14, 2018. More interesting news about SenesTech, Inc. (NASDAQ:SNES) were released by: Prnewswire.com and their article: “SenesTech Announces First Quarter 2018 Financial and Operational Results” published on May 14, 2018 as well as Seekingalpha.com‘s news article titled: “SenesTech’s (SNES) CEO Dr. Loretta Mayer on Q1 2018 Results – Earnings Call Transcript” with publication date: May 15, 2018.

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company has market cap of $5.29 million. The firm focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It currently has negative earnings. It is also developing a pipeline of fertility control and animal health products, including plant fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: